Tobii’s industry-leading eye-tracking technology will be utilized to provide innovative gaze-directed interface for ControlRad’s radiation reduction solutions.

PHILADELPHIA, PA – October. 30, 2018 – ControlRad, Inc., a medical technology company focused on dramatically reducing unnecessary radiation exposure to patients and physicians during fluoroscopic procedures, announced today a partnership with Stockholm-based Tobii AB, the world leader in eye-tracking technology. Tobii will be the exclusive source of ControlRad’s eye-tracker interface for its solution that provides up to 75% radiation reduction technology without reducing image quality or impacting provider workflow.



Sign up for our mailing list to get the latest ControlRad news.

Please let us know your name.
Please let us know your email address.
Invalid Input



Download Brochure